A detailed history of Diversified Trust CO transactions in Alector, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 14,102 shares of ALEC stock, worth $35,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,102
Previous 14,102 -0.0%
Holding current value
$35,960
Previous $64,000 1.56%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

BUY
$3.77 - $8.39 $5,809 - $12,928
1,541 Added 12.27%
14,102 $112,000
Q3 2023

Nov 17, 2023

BUY
$5.2 - $8.77 $3,572 - $6,024
687 Added 5.79%
12,561 $81,000
Q1 2023

Apr 07, 2023

BUY
$5.85 - $9.84 $69,462 - $116,840
11,874 New
11,874 $73,000
Q3 2022

Oct 14, 2022

SELL
$8.19 - $13.2 $13,595 - $21,912
-1,660 Reduced 8.98%
16,818 $159,000
Q2 2022

Jul 12, 2022

BUY
$7.65 - $14.24 $141,356 - $263,126
18,478 New
18,478 $188,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $211M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.